Chiome Bioscience Company
Chiome Bioscience is to commercialize the innovative ADLib'antibody generation technology invented at RIKEN.
Technology:
Others
Industry:
PharmTech
Headquarters:
Tokyo, Tokyo, Japan
Founded Date:
2005
Employees Number:
11-50
Funding Status:
IPO
Register and Claim Ownership